{"id":"W2896753349","doi":"10.1093/annonc/mdy299.011","title":"A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Clinical endpoint; Oncology; Phases of clinical research; Adverse effect; SMARCA4; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507167,0.001111002,0.0009133301,0.0002550432,0.00032886,0.0005873977,0.0005587597,0.0008052172,0.004872057],"category_scores_gemma":[0.0005515431,0.000474288,0.0006553805,0.0002416875,0.0004796768,0.0005074752,0.0003104882,0.001586643,0.001022927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006158958,"about_ca_system_score_gemma":0.001700142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009245732,"about_ca_topic_score_gemma":0.00449117,"domain_scores_codex":[0.9997357,0.0001210228,0.00001241478,0.00005327409,0.00002738714,0.0000502001],"domain_scores_gemma":[0.9996811,0.00003282719,0.00007722792,0.00002911058,0.00002552252,0.0001542904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7182702,0.05475547,0.01607709,0.001065368,0.001873475,0.0004295198,0.0004751763,0.00273031,0.09897645,0.0006595898,0.01418411,0.09050333],"study_design_scores_gemma":[0.6305629,0.3283062,0.02266845,0.00005141103,0.0007391452,0.0006013794,0.0001039093,0.001047552,0.005707169,0.0002964122,0.009883936,0.00003135021],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854447,0.001338381,0.0009451804,0.0004598678,0.00009194056,0.005034111,0.004180444,0.0001391064,0.002366209],"genre_scores_gemma":[0.97373,0.001662201,0.004526995,0.001099175,0.000118776,0.006327088,0.006678381,0.00005021269,0.005807247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004872057,"threshold_uncertainty_score":0.01629865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02693529737998856,"score_gpt":0.3615123025811358,"score_spread":0.3345770052011472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}